臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

关于TAIR
	计画说明

浏览
	典藏机构
	作者
	题名
	日期
	统计图表
	机构即时统计
	学术趋势

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作权
	出版社及期刊政策查询
	TAIR著作权会议记录

相关连结
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

跳至:
或输入年份:

从最近的开始

由旧到新排序

显示项目 2235491-2235540 / 2346973 (共46940页)
<< < 44705 44706 44707 44708 44709 44710 44711 44712 44713 44714 > >>
每页显示[10|25|50]项目

机构	日期	题名	作者
臺大學術典藏	2021-09-04T06:11:30Z	Successful treatment of chronic hepatitis B and D with pegylated-interferon plus entecavir	Chen G.-Y.; Su T.-H.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:30Z	Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection	Cheng H.-R.; JIA-HORNG KAO; Wu H.-L.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Su T.-H.; Chen P.-J.; Chen D.-S.; Liu C.-J.
臺大學術典藏	2021-09-04T06:11:31Z	On-treatment low serum HBV RNA level predicts initial virological response in chronic hepatitis B patients receiving nucleoside analogue therapy	Huang Y.-W.; Takahashi S.; Tsuge M.; Chen C.-L.; Wang T.-C.; Abe H.; Hu J.-T.; Chen D.-S.; Yang S.-S.; Chayama K.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:31Z	Perspectives and control of hepatitis B virus infection in Taiwan	Lin C.-L.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:31Z	Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients	Wang C.-C.; Liu C.-H.; Lin C.-L.; Wang P.-C.; Tseng T.-C.; Lin H.H.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:32Z	Serum biomarkers predictive of significant fibrosis and cirrhosis in chronic hepatitis B	Lin C.-L.; Liu C.-H.; Wang C.-C.; Liang C.-C.; Su T.-H.; Liu C.-J.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:32Z	Slow decline of hepatitis B burden in general population: Results from a population-based survey and longitudinal follow-up study in Taiwan	Chen C.-L.; Yang J.-Y.; Lin S.-F.; Sun C.-A.; Bai C.-H.; You S.-L.; Chen C.-J.; JIA-HORNG KAO; Chen P.-J.; Chen D.-S.
臺大學術典藏	2021-09-04T06:11:33Z	Hepatitis B virus genotypes and variants	Lin C.-L.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:33Z	Hepatitis B vaccination and prevention of hepatocellular carcinoma	JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:33Z	Reimbursement policies in the Asia-Pacific for chronic hepatitis B	Lim S.G.; Amarapurkar D.N.; Chan H.L.-Y.; Crawford D.H.; Gane E.J.; Han K.-H.; Ahn S.H.; Jafri W.; Jia J.; JIA-HORNG KAO; Lesmana L.A.; Lesmana C.R.A.; Mohamed R.; Phiet P.H.; Piratvisuth T.; Sarin S.K.; Sollarno J.D.; Eguchi Y.; Mahtab M.-A.; Lee K.H.
臺大學術典藏	2021-09-04T06:11:34Z	Viral hepatitis: HBV cure-can we pin our hopes on immunotherapy?	Yang H.-C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:34Z	Treating immune-tolerant Hepatitis B	Tseng T.-C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:34Z	Micro-evolution of the hepatitis B virus genome in hepatitis B e-antigen-positive carriers: Comparison of genotypes B and C at various immune stages	Liu C.-J.; Chen T.-C.; Chen P.-J.; Wang H.-Y.; Tseng T.-C.; Cheng H.-R.; Liu C.-H.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:35Z	What can we learn from hepatitis B virus clinical cohorts?	Lin C.-L.; Tseng T.-C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:35Z	Hepatitis B virus infection and metabolic syndrome: Fact or fiction?	Wang C.-C.; Tseng T.-C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:35Z	Asunaprevir-containing regimens for the treatment of hepatitis C virus infection	Yang S.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:36Z	Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: Molecular mechanisms and clinical significance	Yang H.-C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:36Z	Risk stratification of HBV infection in Asia-Pacific region	JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:36Z	The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo	Lin S.-R.; Yang H.-C.; Kuo Y.-T.; Liu C.-J.; Yang T.-Y.; Sung K.-C.; Lin Y.-Y.; Wang H.-Y.; Wang C.-C.; Shen Y.-C.; Wu F.-Y.; JIA-HORNG KAO; Chen D.-S.; Chen P.-J.
臺大學術典藏	2021-09-04T06:11:37Z	Molecular mechanism and treatment of viral hepatitis-related liver fibrosis	Su T.-H.; JIA-HORNG KAO; Liu C.-J.
臺大學術典藏	2021-09-04T06:11:37Z	Nanomedicines in the treatment of hepatitis C virus infection in Asian patients: Optimizing use of peginterferon alfa	Liu C.-H.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:37Z	Triple therapy for hepatitis C virus infection in patients receiving hemodialysis	Liu C.-H.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:38Z	HBeAg-positive chronic hepatitis B: Why do I treat my patients with pegylated interferon?	JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:38Z	A pilot study of add-on oral hypoglycemic agents in treatment-na?ve genotype-1 chronic hepatitis C patients receiving peginterferon alfa-2b plus ribavirin	Hsu C.-S.; Hsu S.-J.; Lin H.H.; Tseng T.-C.; Wang C.-C.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:38Z	Baseline hepatitis B surface antigen quantitation can predict virologic response in entecavir-treated chronic hepatitis B patients	Wang C.-C.; Tseng T.-C.; Wang P.-C.; Lin H.H.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:38Z	Reduced toll-like receptor 9 expression on peripheral C D14+ monocytes of chronic hepatitis B patients and its restoration by effective therapy	Huang Y.-W.; Hsu C.-K.; Lin S.-C.; Wei S.-C.; Hu J.-T.; Chang H.-Y.; Liang C.-W.; Chen D.-S.; Chen P.-J.; Hsu P.-N.; Yang S.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:39Z	All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: A multinational, phase 3, multicohort study	Manns M.; Pol S.; Jacobson I.M.; Marcellin P.; Gordon S.C.; Peng C.-Y.; Chang T.-T.; Everson G.T.; Heo J.; Gerken G.; Yoffe B.; Towner W.J.; Bourliere M.; Metivier S.; Chu C.-J.; Sievert W.; Bronowicki J.-P.; Thabut D.; Lee Y.-J.; JIA-HORNG KAO; McPhee F.; Kopit J.; Mendez P.; Linaberry M.; Hughes E.; Noviello S.
臺大學術典藏	2021-09-04T06:11:39Z	Increased risk of cirrhosis and its decompensation in chronic hepatitis C patients with new-onset diabetes: A nationwide cohort study	Huang Y.-W.; Yang S.-S.; Fu S.-C.; Wang T.-C.; Hsu C.-K.; Chen D.-S.; Hu J.-T.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:40Z	Plasma adipokines and risk of hepatocellular carcinoma in chronic hepatitis B virus-infected carriers: A prospective study in Taiwan	Chen C.-L.; Yang W.-S.; Yang H.-I.; Chen C.-F.; You S.-L.; Wang L.-Y.; Lu S.-N.; Liu C.-J.; JIA-HORNG KAO; Chen P.-J.; Chen D.-S.; Chen C.-J.
臺大學術典藏	2021-09-04T06:11:40Z	Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: Clinical and mechanistic implications	Wu H.-L.; JIA-HORNG KAO; Chen T.-C.; Wu W.-H.; Liu C.-H.; Su T.-H.; Yang H.-C.; Chen D.-S.; Chen P.-J.; Liu C.-J.
臺大學術典藏	2021-09-04T06:11:40Z	Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously	Cheng H.-R.; JIA-HORNG KAO; Wu H.-L.; Chen T.-C.; Tseng T.-C.; Liu C.-H.; Su T.-H.; Chen P.-J.; Chen D.-S.; Liu C.-J.
臺大學術典藏	2021-09-04T06:11:41Z	Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters	Tseng T.-C.; Liu C.-J.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:41Z	Peginterferon α in the treatment of chronic hepatitis B	Tseng T.-C.; JIA-HORNG KAO; Chen D.-S.
臺大學術典藏	2021-09-04T06:11:42Z	Vascular and hepatic enhancements at MR imaging: Comparison of Gd-EOB-DTPA and Gd-DTPA in the same subjects	Lin Y.-H.; Hwang R.-M.; Chen B.-B.; Hsu C.-Y.; Yu C.-W.; JIA-HORNG KAO; Lee H.-S.; Liang P.-C.; Wei S.-Y.; Shih T.T.F.
臺大學術典藏	2021-09-04T06:11:42Z	Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirin	Chen M.-Y.; Liu C.-H.; Chen T.-C.; Su T.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO; Liu C.-J.
臺大學術典藏	2021-09-04T06:11:42Z	Higher adherence with 3-year entecavir treatment than lamivudine or telbivudine in treatment-na?ve Taiwanese patients with chronic hepatitis B	Chien R.-N.; Peng C.-Y.; JIA-HORNG KAO; Hu T.-H.; Lin C.-C.; Hu C.-T.; Chen C.-Y.; Hsieh T.-Y.; Lin H.-C.; Chuang W.-L.
臺大學術典藏	2021-09-04T06:11:43Z	Factors affecting the diagnostic accuracy of ultrasonography in assessing the severity of hepatic steatosis	Wang C.-C.; Hsieh T.-C.; Tseng T.-C.; Wang P.-C.; Hsu C.-S.; Lin H.H.; Wang L.-Y.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:43Z	Hepatic necro-inflammation and elevated liver enzymes: Evaluation with MRI perfusion imaging with gadoxetic acid in chronic hepatitis patients	Chen B.-B.; Hsu C.-Y.; Yu C.-W.; JIA-HORNG KAO; Lee H.-S.; Liang P.-C.; Wei S.-Y.; Hwang R.-M.; Shih T.T.-F.
臺大學術典藏	2021-09-04T06:11:43Z	Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy	Su T.-H.; Liu C.-J.; Yang H.-C.; Jeng Y.-M.; Cheng H.-R.; Liu C.-H.; Tseng T.-C.; Ling T.-Y.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:44Z	Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: A randomized trial	Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Chen S.-I.; Lin J.-W.; Yang S.-S.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:44Z	Increased risk of cirrhosis and its decompensation in chronic hepatitis B patients with newly diagnosed diabetes: A nationwide cohort study	Huang Y.-W.; Wang T.-C.; Lin S.-C.; Chang H.-Y.; Chen D.-S.; Hu J.-T.; Yang S.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:45Z	Biphasic pattern of depression and its predictors during pegylated interferon-based therapy in chronic hepatitis B and C patients	Huang Y.-W.; Hu J.-T.; Hu F.-C.; Chang C.-J.; Chang H.-Y.; JIA-HORNG KAO; Yang S.-S.; Chen D.-S.
臺大學術典藏	2021-09-04T06:11:45Z	IL28B genotype on HCV infection in Asia	Liu C.-H.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:45Z	Consolidation therapy for HBeAg-positive Asian chronic hepatitis B patients receiving lamivudine treatment: A multicentre study	Dai C.-Y.; Tseng T.-C.; Wong G.L.H.; Huang J-F.; Wong V.W.S.; Liu C.-J.; Yu M.-L.; Chuang W.-L.; JIA-HORNG KAO; Yuen Chan H.L.; Chen D.-S.
臺大學術典藏	2021-09-04T06:11:45Z	Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers	Tseng T.-C.; Liu C.-J.; Chen C.-L.; Yang H.-C.; Su T.-H.; Wang C.-C.; Yang W.-T.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:46Z	Interferon-based therapy reduces risk of stroke in chronic hepatitis C patients: A population-based cohort study in Taiwan	Hsu C.-S.; JIA-HORNG KAO; Chao Y.-C.; Lin H.H.; Fan Y.-C.; Huang C.-J.; Tsai P.-S.
臺大學術典藏	2021-09-04T06:11:46Z	Interferon-Based Therapy Decreases Risks of Hepatocellular Carcinoma and Complications of Cirrhosis in Chronic Hepatitis C Patients	Hsu C.-S.; Huang C.-J.; JIA-HORNG KAO; Lin H.H.; Chao Y.-C.; Fan Y.-C.; Tsai P.-S.
臺大學術典藏	2021-09-04T06:11:47Z	Global perspective on the natural history of chronic hepatitis B: Role of hepatitis B virus genotypes A to J	Liu C.-J.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:47Z	Hepatitis B virus genotypes: Clinical relevance and therapeutic implications	Lin C.-L.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:47Z	Hepatitis B viral factors and treatment responses in chronic hepatitis B	Lin C.-L.; JIA-HORNG KAO

Showing items 2235491-2235540 of 2346973 (46940 Page(s) Totally)
<< < 44705 44706 44707 44708 44709 44710 44711 44712 44713 44714 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 总笔数 :2854037
	造访人次 : 45367962 在线人数 : 764 教育部委托研究计画计画执行:国立台湾大学图书馆